Skip to content

IMUX · NASDAQ

Immunic (IMUX) Stock Price & Fundamentals

$623.67−0.01%−$0.08End-of-day price as of Oct 9, 2026

Immunic (IMUX) closed at $623.67 on Oct 9, 2026, down 0.01% from the previous close of $623.75.

Share price, past year

1Y +27.22%

52-week range $486.23 – $649.41. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$623.67
Sep 30, 2026$619.03
Aug 31, 2026$625.11
Jul 31, 2026$633.08
Jun 30, 2026$635.58
May 29, 2026$597.64
Apr 30, 2026$609.39
Mar 31, 2026$611.93
Feb 27, 2026$573.06
Jan 30, 2026$535.88
Dec 31, 2025$557.33
Nov 28, 2025$531.54
Oct 31, 2025$505.43

Key statistics

Market cap
$8.51B
P/E (TTM)
305.7
EPS (TTM)
$2.04
Net income (TTM)
−$111.57M
Shares outstanding
13.6M
52-week range
$486.23 – $649.41

Immunic's market cap is $8.51B, based on a share price of $623.67 and 13.6M shares outstanding as of Jun 30, 2026.

Financials

Immunic's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.

Immunic reported a net loss of $97.17M in fiscal 2025.

Company profile

Name
Immunic, Inc.
Ticker
IMUX
Exchange
NASDAQ
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
1200 Avenue Of The Americas, Suite 200, New York, X1 10036
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001280776

Recent SEC filings

Frequently asked questions

What is Immunic's stock price?

Immunic (IMUX) closed at $623.67 on Oct 9, 2026, down 0.01% from the previous close of $623.75.

What is Immunic's market cap?

Immunic's market cap is $8.51B, based on a share price of $623.67 and 13.6M shares outstanding as of Jun 30, 2026.

What is IMUX's P/E ratio?

Immunic's price-to-earnings ratio is 305.7, based on trailing twelve-month diluted EPS of $2.04.

Does Immunic pay a dividend?

Yes. Immunic declared $0.00 per share in dividends for fiscal 2025.

Sources and methodology

Fundamentals come from Immunic, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures